If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Management Appointments

26 Jul 2006 07:01

Torex Retail PLC26 July 2006 Torex Retail Plc ("the Company") Announces non-Board appointments for Operational Management to deliver Organic Growth Strategy & Further strengthening of Finance Function Torex Retail Plc, an international market leader in the provision of innovativeretail IT systems, announces that following the completion of its 2006acquisition strategy, the Company's operational management is to be restructuredinto five newly created Divisions in order to fully focus on maximising organicgrowth opportunities in the coming period. As a result, the following senior internal appointments have been made,reporting directly to the Plc Board: • CEO of UK General Retail: Doug Hargrove (age 39) (Previously Chief Operating Officer, UK & Ireland) • CEO of Overseas Business: Phil Cox (age 39) (Previously Group Treasury Officer) • CEO of Hospitality & QSR ('Quick Service Restaurants'): Keith Pascal (age 41) (Previously VP Sales & Marketing, Savista Inc.) • CEO of P&C ('Petroleum & Convenience'): Brendan Kavanagh (age 41) (Previously Head of P&C Division Worldwide) • CEO of Americas General Retail: Mike Hess (age 43) (Previously President & COO of Torex North America) The Company is also pleased to today announce the appointment of Marcus Leek asGroup Finance Director with immediate effect. Marcus (age 31) joins from 4uBusiness Ltd (a part of the Caudwell Group) where he held the position ofFinance Director. He also has considerable experience in the retail sectorhaving worked for J. Sainsbury plc and Bells Stores Limited in a variety ofsenior finance roles. Marcus is an industry trained Chartered Accountant. Reporting directly to Mark Pearman, Marcus will be responsible for all groupfinancial matters. Marcus will be part of the wider senior management team atTorex as well as playing a leading role in the finance function. He will alsoplay an active part in investor relations. Continuing Plc Finance Director and Business Development Director Mark Pearmancommented: "I am delighted that we have secured the services of Marcus. He is highlyqualified and his relevant industry experience and energy make him the choicecandidate; we expect him to make an immediate contribution to the Group". Supporting Marcus will be Mark Lovett (age 32) as UK Finance Director. Markjoins Torex Retail from Xansa plc, an IT and Business Process Outsourcingprovider, where for the past 12 months he was Finance Director for the Financialand Business services division. Prior to that, Mark was Financial Controller forthe Retail division, where he worked on new and existing contracts withretailers such as Boots, Tesco, B&Q and Marks & Spencer. Having trained as aChartered Accountant with KPMG, Mark subsequently held a number of financepositions with Misys plc in the UK, North America and Far East. On the new management appointments, Chairman and Chief Executive Chris Moorestated: "Following the completion of our recent acquisition strategy, we have nowachieved the sufficient scale necessary to compete globally. It was clear thatas we entered our next phase of organic-focused growth, we needed an experiencedmanagement team and structure that could successfully drive this strategythroughout the Group. The five new CEO appointments reflect this and will alsomake for a clearer reporting structure at Board level. It was also important for us to strengthen our internal finance function toreflect the new size of the Company. I am delighted to have secured thehigh-calibre services of Marcus Leek and Mark Lovett who join us with clearfinancial and industry focus in Retail and IT". Torex Retail Plc will announce interim results for the six months ended 30 June2006 on Monday, 14 August. As stated in the recent 11 July trading update,management expect these results to be slightly ahead of analyst's expectationsand remain confident for the full year. -Ends- Enquiries: Torex Retail PlcChris Moore, Chairman & Chief Executive +44 (0)870 300 6061 Citigate Dewe Rogerson +44 (0)20 7638 9571Seb Hoyle / Lucie Holloway This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Mar 20207:00 amRNSUpdate in relation to working capital position
20th Mar 20207:00 amRNSDirectorate Change
6th Feb 20207:15 amEQSHardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
4th Feb 202011:47 amRNSResolution of Cyber Security Incident
28th Jan 202010:02 amRNSNotice of cyber security incident
22nd Jan 20207:00 amRNSTrading Update
14th Jan 20204:40 pmRNSSecond Price Monitoring Extn
14th Jan 20204:35 pmRNSPrice Monitoring Extension
21st Nov 20194:35 pmRNSPrice Monitoring Extension
18th Nov 20194:03 pmRNSDirectorate Change
14th Nov 20194:00 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSUpdated loan facility agreement with MidCap
13th Nov 20193:35 pmRNSHolding(s) in Company
13th Nov 20193:17 pmRNSHolding(s) in Company
11th Nov 20192:05 pmRNSSecond Price Monitoring Extn
11th Nov 20192:00 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSUpdate in relation to loan facility
17th Oct 20194:27 pmRNSHolding(s) in Company
17th Oct 20197:00 amRNSTrading Update
15th Oct 20193:27 pmRNSHolding(s) in Company
3rd Oct 20197:00 amRNSDermaPure Product Line Extension Launched
10th Sep 20197:00 amRNSUnaudited Interim Results
28th Aug 20197:00 amRNSAppointment of CFO
15th Aug 20197:00 amRNSAdditional manufacturing capacity secured
1st Aug 20197:00 amRNSDirectorate Change
8th Jul 20195:03 pmRNSHolding(s) in Company
20th Jun 20192:23 pmEQSHardman & Co Research: Tissue Regenix (TRX): Credit facilities expand cash runway to 2021
7th Jun 20192:55 pmRNSIssue of Equity and Total Voting Rights
4th Jun 20197:00 amRNSNotice of AGM
4th Jun 20197:00 amRNSSecures Credit Facilities of up to $20m
4th Jun 20197:00 amRNSAnnual Results for the year ended 31 December 2018
21st May 20197:00 amRNSCEO to return to full time duties
10th Apr 20197:20 amEQSHardman & Co Research: Tissue Regenix (TRX): Expanded GPO coverage secured
4th Apr 20197:26 amRNSExpands US GPO coverage for DermaPure
18th Feb 20197:00 amRNSChange of Adviser
6th Feb 201911:05 amRNSSecond Price Monitoring Extn
6th Feb 201911:00 amRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSTrading Update
17th Dec 201811:56 amEQSHardman & Co Research: Tissue Regenix (TRX): 2018 in review: foundations laid for osteobiologics
6th Dec 20187:00 amRNSInterim Management Change
13th Nov 20187:00 amRNSPan European distribution agreement with Arthrex
29th Oct 20187:00 amRNSGareth Jones commences position as CFO
14th Sep 20187:16 amEQSHardman & Co Research: Tissue Regenix (TRX): Strategy delivering growth above expectations
3rd Sep 20187:00 amRNSUnaudited Interim Results
2nd Aug 201810:10 amEQSHardman & Co Research: Tissue Regenix (TRX): 1H'18 preview: organic plus inorganic growth
2nd Aug 20187:00 amRNSNotice of Interim Results
4th Jul 20187:00 amRNSAppointment of CFO
25th Jun 20187:00 amRNSHTA License granted and UK distribution Agreement
21st Jun 20187:10 amRNSTRX BioSurgery wins GPO Supplier Horizon Award
18th Jun 20187:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.